Dixie Botanicals® Canada Launches CBD-Only Products Nationwide

International Brand Introduces New CBD-only Products to the Canadian Market

NANAIMO, British Columbia, Oct. 10, 2018 /CNW/ -- Dixie Botanicals Canada®, a well-known brand leader in the global cannabis industry, today announced the launch of its cannabidiol (CBD)-only product line in Canada in partnership with Canadian extraction and formulation company Salvation Botanicals, Ltd. ("Salvation").

Dixie Botanicals Canada® products are crafted using expertly cultivated and scientifically extracted cannabis oil, free of herbicides, pesticides and chemical fertilizers. The all-natural products are tested multiple times to ensure consumers are provided with the purest CBD products. Products will be available in a variety of delivery methods including liquids, capsules, and oral sprays.

"This an incredible time for the Canadian cannabis industry," said Dixie Botanicals Canada® President Michael Coleman. "We are excited to be making our mark on such a historic milestone by introducing products into such a burgeoning market. Dixie Botanicals Canada offers a collection of new and innovative products while consistently meeting their ever-growing customers' needs."

According to a recent report by Deloitte, the new legislation of recreational cannabis in Canada is expected to see consumers spend up to $7 billion on cannabis related products, exceeding Canadian liquor sales of $5 billion. The report also projected overall cannabis consumption to increase by up to 35 percent.

"This launch is a major milestone for both companies as we enter a new era for the Canadian cannabis industry," said Salvation Botanicals Chief Financial Officer Rob McIntyre. "Dixie Botanicals Canada is a brand that values its customers and we look forward to introducing these new products to the market."

Salvation Botanicals, the manufacturer of Dixie Botanicals Canada® products, was founded on a commitment to the science of standardization and consumer protection through analytical testing and the development of stringent production processes. Salvation Botanicals has developed high-volume production methods based on their understanding of high-quality, standardized cannabinoid products.

About Dixie Botanicals Canada®
Regarded as one of the most well-recognized brands in the industry, Dixie Botanicals® Canada offers innovative cannabidiol (CBD) products for health-conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists who work to integrate our cannabis oil into a variety of unique products. We test and analyze our products from seed to shelf, ensuring that every natural product we offer is free from contaminants and of the highest quality possible. For more information, visit: https://dixiebotanicals.ca.

About Salvation Botanicals, Ltd.
Salvation Botanicals is a private company based in Vancouver Island, British Columbia, that is dedicated to the testing and production of high quality standardized cannabinoid products for the international cannabis market. Salvation operates one of the first analytics laboratories in Canada, licensed by Health Canada to test cannabis and derivatives.

Salvation Botanicals holds a Dealer's License under the Controlled Substances Act, with authority to extract and produce oil within Health Canada guidelines. In 2016 Health Canada granted Salvation a Hemp Processing License (HPL) permitting production and sale and export of seed & grain and its derivatives.  

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: the terms and conditions of the proposed transaction; the terms and conditions of the proposed private placement; use of funds; and the business and operations of the Company after the proposed change of business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the cannabis industry in North America. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Salvation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 858-264-6600 
[email protected] 
www.cmwmedia.com

SOURCE Dixie Botanicals Canada